2Schiller JH,Kim K,Hutson P,et al. Phase Ⅱ study of Topotecan in patients with extensive stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial [J].J Clin Oncol, 1996,14(8):2345-2352.
3Ardizzoni A, Hansen H, Dombernowsky P, et al. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase Ⅱ study in patients with refractory and sensitive disease [J]. J Clin Oncol,1997,15(5):2090-2096.
4Von-Pawel J,Schiller JH,Shepherd FA,et al. Topotecan Versus Cyclophosphamide ,Doxorubicin,and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer [J].Journal of Clin Oncol, 1999,17(2):658-667.
二级参考文献10
1Grant SC,Gralla RJ,Kriss MG,et al.Single agent chemotherapy trial in small cell lung cancer, 1970 to 1990: the case for studies in previously treated patients[].Journal of Clinical Oncology.1992
2Albain KS,Crowley JJ,Hutchins L,et al.Predictors of survival following relapse or progression of small cell lung cancer[].Cancer.1993
3Armstrong D,Rowinsky E,Freedman R,et al.A phase II trial of topotecan as salvage therapy in epithelial ovarian cancer[].Proceedings of the American Society of Clinical Oncology.1995
4Perel Soler R,Glisson BE,Lee JS,et al.Treatment of patients with small cell lung cancer refractory to etoposide and cisplatin with the topoismerase I poison[].Journal of Clinical Oncology.1996
5Shiller JH,Kim K,Hutson P,et al.Phase II study of topotecan in patients with extensive stage small-cell carcinoma of the lung: an eastern cooperative oncology group trial[].Journal of Clinical Oncology.1996
6Von Pawel J,Schiller JH,Shepherd FA,et al.Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer[].Journal of Clinical Oncology.1999
7Von Pawel J,Depierre A,Hans K,et al.Topotecan (Hycamtin) in small cell lung cancer after failure of first line therapy-multicentre phase II study[].European Journal of Cancer.1997
8Eckardt J,Gralla R,Palmer MC,et al.Topotecan as second line therapy in patients with small cell lung cancer: a phase II study[].Oncology.1996
9Huinink WB,Martin G,Games C,et al.Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer[].Journal of Clinical Oncology.1997
10Kollmannsberger C,Mross K,Jakob A,et al.Topotecan-a novel topoisomerase I inhibitor: pharmacology and clinical experience[].Oncology.1999
